IHI:NYE-iShares U.S. Medical Devices ETF (USD)

ETF | Health |

Last Closing

USD 59.96

Change

-0.11 (-0.18)%

Market Cap

N/A

Volume

0.58M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-19 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-0.73 (-0.51%)

USD 40.46B
FHLC Fidelity® MSCI Health Care In..

-0.24 (-0.36%)

USD 2.91B
FXH First Trust Health Care AlphaD..

-0.42 (-0.39%)

USD 1.19B
XHE SPDR® S&P Health Care Equipme..

+0.31 (+0.35%)

USD 0.22B
IDNA iShares Genomics Immunology an..

+0.02 (+0.09%)

USD 0.15B
SBIO ALPS Medical Breakthroughs ETF

+0.47 (+1.30%)

USD 0.13B
XHS SPDR® S&P Health Care Service..

+0.48 (+0.52%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

+0.11 (+0.38%)

USD 0.06B
BBP Virtus LifeSci Biotech Product..

+0.87 (+1.44%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

+0.24 (+0.93%)

USD 0.01B

ETFs Containing IHI

MSSS 10.17 % 0.00 %

N/A

N/A
ETAC:CA 0.00 % 1.76 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.10% 95% A 59% D-
Dividend Return 0.30% 31% F 4% F
Total Return 11.40% 95% A 52% F
Trailing 12 Months  
Capital Gain 20.62% 71% C- 64% D
Dividend Return 0.53% 44% F 5% F
Total Return 21.14% 71% C- 58% F
Trailing 5 Years  
Capital Gain 41.25% 76% C+ 67% D+
Dividend Return 2.49% 44% F 6% D-
Total Return 43.74% 71% C- 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 3.63% 38% F 47% F
Dividend Return 4.03% 43% F 41% F
Total Return 0.40% 47% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 23.75% 38% F 46% F
Risk Adjusted Return 16.98% 43% F 34% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.